3701 results
Rome IV Criteria for the Irritable Bowel Syndrome.

#Diagnosis #PrimaryCare #IBS #IrritableBowelSyndrome #RomeIV #Criteria
Rome IV Criteria ... #PrimaryCare #IBS ... IrritableBowelSyndrome #RomeIV
Rome III criteria emphasize importance of stool consistency to distinguish 3 subtypes of IBS - JAMA
Rome III criteria ... 3 subtypes of IBS ... #PrimaryCare #IBS ... IrritableBowelSyndrome #RomeIII
Irritable Bowel Syndrome (IBS) - Diagnosis and Management Summary
Diagnosis:
 • Use a positive diagnostic strategy with
Bowel Syndrome (IBS ... IBS is NOT a diagnosis ... • Rome IV Criteria ... Treatment: • Global IBS ... 75-100mg QD) • IBS-C
Irritable Bowel Syndrome (IBS) - Diagnosis and Workup Summary
Use a positive diagnostic strategy with minimal testing.
Bowel Syndrome (IBS ... IBS is NOT a diagnosis ... Rome IV Criteria ... fewer polyps in IBS ... vs non-IBS!
Paradoxical Breathing in Flail Chest

Video via Dr. Carlos Romero

#Flail #Chest #Paradoxical #Breathing #Pulmonary #Respiratory #clinical #video
Carlos Romero
IBS-C Pharmacotherapy

Polyethylene glycol
Lubiprostone
Linaclotide
Plecanatide
Tegaserod
Tenapanor

#IBSC #IBS #Constipation #Irritable #Bowel #Syndrome #pharmacology #table #comparison #management #treatment
IBS-C Pharmacotherapy ... Tenapanor #IBSC ... #IBS #Constipation
IBS-D Pharmacotherapy

Loperamide
Rifaximin
Eluxadoline
Alosetron
Antispasmodics
Tricyclic antidepressants
SSRIs

#IBSD #IBS #Diarrhea #Irritable #Bowel #Syndrome #pharmacology #table #comparison #management #treatment
IBS-D Pharmacotherapy ... antidepressants SSRIs #IBSD ... #IBS #Diarrhea
Blood Gas (ABG) Interpretation and Acid-Base Pathology
1- Does the patient have an acidosis or an alkalosis?
the pH 2- What is ... pCO2 Think ROME ... If pCO2 change is ... primary problem is ... respiratory) 3- Is
Suggested algorithm for treating irritable bowel syndrome-diarrheal type (IBS-D) 

#IBSD #diarrhea #Algorithm #irritable #bowel #syndrome #management
syndrome-diarrheal type (IBS-D ... ) #IBSD #diarrhea
JAK Inhibitors in 2019

Role in the therapeutic strategy in 2019
 • RA: 2nd line after failure
By Romain Muller